Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 4101-4150 of 6028 result(s).
CYDY CytoDyn Inc
01/27/2021 2:24:10 PM
What is a realistic SP? Exactly wha (5)
CYDY CytoDyn Inc
01/27/2021 2:00:00 PM
and very much in business For now. (2)
CYDY CytoDyn Inc
01/27/2021 3:42:14 AM
I'll believe his point is that with (4)
CYDY CytoDyn Inc
01/27/2021 3:02:48 AM
Thank you! I've always believed it'
CYDY CytoDyn Inc
01/27/2021 2:40:07 AM
If all indications were a weekly in (7)
CYDY CytoDyn Inc
01/27/2021 1:48:57 AM
For maraviroc the liver breaks down (2)
CYDY CytoDyn Inc
01/26/2021 6:18:00 PM
Andy is lying about not getting bur (3)
CYDY CytoDyn Inc
01/26/2021 5:33:08 PM
A long time ago when Cytodyn was qu (1)
CYDY CytoDyn Inc
01/26/2021 4:57:15 PM
My only concern with LH, is the cos (5)
CYDY CytoDyn Inc
01/26/2021 3:35:56 PM
It would if anyone was willing to p (1)
CYDY CytoDyn Inc
01/26/2021 2:12:44 PM
The best thing I heard on that vide (16)
CYDY CytoDyn Inc
01/26/2021 2:08:46 PM
Don't we have an open gap at .36 ce (2)
CYDY CytoDyn Inc
01/26/2021 12:43:55 PM
https://www.medrxiv.org/content/1 (2)
CYDY CytoDyn Inc
01/26/2021 11:44:06 AM
So I like the idea of a CC, but if (1)
CYDY CytoDyn Inc
01/26/2021 11:42:48 AM
That's the problem with being incon (2)
CYDY CytoDyn Inc
01/26/2021 11:41:03 AM
Maybe the FDA will release him once
CYDY CytoDyn Inc
01/26/2021 10:37:46 AM
I’d be content if he just tweeted (5)
CYDY CytoDyn Inc
01/26/2021 7:19:41 AM
Any double blind, placebo controlle (4)
CYDY CytoDyn Inc
01/26/2021 3:20:09 AM
I miss all the fun stuff. :( (1)
CYDY CytoDyn Inc
01/25/2021 9:14:13 PM
Turns out that harnessing the colle (6)
CYDY CytoDyn Inc
01/25/2021 4:04:23 PM
I would imagine that with positive (2)
CYDY CytoDyn Inc
01/25/2021 6:10:41 AM
I tend to go conservative on my eva (5)
CYDY CytoDyn Inc
01/24/2021 11:02:07 PM
From the link - If you go and look (7)
CYDY CytoDyn Inc
01/24/2021 9:49:29 PM
We have no idea what the deal is wi (4)
CYDY CytoDyn Inc
01/24/2021 7:36:26 PM
You are correct. I was reading PaO2 (2)
CYDY CytoDyn Inc
01/24/2021 6:45:15 PM
Very good find!
CYDY CytoDyn Inc
01/24/2021 6:42:08 PM
I believe placebo group is less tha (2)
CYDY CytoDyn Inc
01/24/2021 5:53:24 PM
CCR5 blockade downregulates PD-L1 w (3)
CYDY CytoDyn Inc
01/24/2021 1:28:44 PM
If anyone doubts the negative of a (2)
CYDY CytoDyn Inc
01/24/2021 1:24:46 PM
From their trial - Renal Response r (2)
CYDY CytoDyn Inc
01/24/2021 7:21:43 AM
Good job. I have ran across the mol
CYDY CytoDyn Inc
01/24/2021 1:49:25 AM
The concentration of leronlimab in (4)
CYDY CytoDyn Inc
01/24/2021 1:23:47 AM
Whether a combination is goop depen (2)
CYDY CytoDyn Inc
01/24/2021 12:51:41 AM
BLA filing Q2 2021. For Gilead I'm (1)
CYDY CytoDyn Inc
01/23/2021 11:22:40 PM
After reading through the entire pa (7)
CYDY CytoDyn Inc
01/23/2021 3:00:51 PM
You definitely have to dig down int (1)
CYDY CytoDyn Inc
01/23/2021 1:29:39 PM
Did Fauci believe in remdesivir or (1)
CYDY CytoDyn Inc
01/23/2021 1:21:05 PM
How many OLEs were given with unkno (1)
CYDY CytoDyn Inc
01/22/2021 1:46:42 PM
The real reason is because Gamestop (1)
CYDY CytoDyn Inc
01/22/2021 1:45:10 PM
1. (2)
CYDY CytoDyn Inc
01/22/2021 12:42:16 PM
Shorts enter by selling when sp is (1)
CYDY CytoDyn Inc
01/22/2021 9:52:02 AM
my only interest with this board ar (4)
CYDY CytoDyn Inc
01/22/2021 9:33:57 AM
as a shareholder OK, boomer (3)
CYDY CytoDyn Inc
01/21/2021 6:02:34 PM
But hey, I bought a kid on Craigsli (6)
CYDY CytoDyn Inc
01/21/2021 12:09:22 PM
The tropism test would have been do (1)
CYDY CytoDyn Inc
01/21/2021 12:06:03 PM
That's child abuse. You should have (6)
CYDY CytoDyn Inc
01/21/2021 11:59:15 AM
I don’t care who wrote it Because (6)
CYDY CytoDyn Inc
01/21/2021 11:46:53 AM
Citronsource ROFLMAO What next, you (5)
CYDY CytoDyn Inc
01/21/2021 11:45:47 AM
the truth is it wasn’t the qualit (3)
CYDY CytoDyn Inc
01/21/2021 11:42:26 AM
They wanted the rest of the data fr (1)
Go to page:
  • << First
  • < Previous
  • 82
  • 83
  • Next >

Recent Articles

  • Discover the Impressive Growth of Fluor Stock in Five Years
  • Transforming $100 Invested In Wheaton Precious Metals Today
  • BestPropFirms.com Welcomes Tegan Miller as Financial Writer
  • Empowering EHS Professionals Through CoreSkills Workshops
  • Tanya Hart's Impact: Recognized Leader and Advocate for Wellness
  • AUTOCRYPT and Valtech Mobility Unveil Innovative Digital Key Ecosystem
  • When Credit Falls Short: Innovative Alternatives for Underserved Borrowers
  • Bridgehold Achieves Milestone of 10,000 Intelligence Reports
  • Paladin Energy Secures A$300 Million for PLS Project Expansion
  • Altimmune Investors Urged to Act Before Key Class Action Deadline
  • Innovative Digital Key Solutions Unveiled at Major Mobility Event
  • Kevin O'Leary's Multi-Million Dollar Trading Card Investment
  • Paladin Secures A$300M for PLS Project Advancements
  • Investing in Phillips 66: A Journey of Five Years of Growth
  • Exploring the Elegance of the Customized Mercedes-Benz SL-Class
  • Exploring Innovative Digital Key Solutions in Automotive Security
  • Innovative Funding Enables Little Otter Health's Growth in Mental Care
  • Unexpected AI Stock Picks by Financial Giants You Need to Know
  • Investment Growth: Ferguson Enterprises and Its Future
  • Dye & Durham's Notification on Annual Financial Statements Status
  • Why Smart Cameras Are Becoming Essential For Modern Businesses
  • EnviroGold's Private Placement to Fuel Innovative Growth
  • Exploring Natera's Impressive Stock Journey Over Five Years
  • EnviroGold Drives Future Growth with New Funding Initiative
  • Insightful Discussion by Quest Diagnostics at Key Healthcare Event
  • Understanding Proton Therapy: A Pathway to Healthier Lives
  • Tronox Secures $400 Million in Senior Secured Notes Financing
  • Maximize Industrial Visibility with Advanced LED High Bay Systems
  • Transforming a Century Investment: Watts Water Technologies Growth
  • Polaris RZR Team Achieves Historic Baja 400 Victory Again
  • Microsoft Boosts Dividend and Sets Annual Meeting for 2025
  • Investor Insights Into Legal Action Against Telix Pharmaceuticals
  • Creative Brands Expands Horizon with The Gift Wrap Company Deal
  • Transforming Sexual Health: The Impact of Pelvic Tech Tools
  • New Class Action Lawsuit Against V.F. Corporation Unveiled
  • NCLA Seeks D.C. Circuit's Review to Overturn EPA's HFC Control
  • VitalHub Corporation Transition to New Auditor Strengthens Oversight
  • Navigating the Charter Communications Class Action for Investors
  • How Wegovy® Enhances Mental Well-Being and Reduces Food Noise
  • Understanding the P/E Ratio for Servisfirst Bancshares Stock
  • Marwest REIT Declares Monthly Distribution for Trust Units
  • Decade of Growth: $100 Invested in Rambus Now Worth $837
  • Investigation Launched into CoinShares International's Merger
  • Investor Awareness: Vine Hill Capital's Merger Scrutiny Explained
  • Investigation Launched for Tourmaline Bio's Shareholders
  • Potbelly Corporation Investigated for Shareholder Rights Violations
  • The Economics of Platform-Based Investing: How Commission-Free Models Are Reshaping Financial Markets
  • Vimeo, Inc. Under Investigation: Is the Sale Fair for Shareholders?
  • Safeguarding Quality: The Launch of Ubiquinol Verified Program
  • KBR, Inc. Shareholders Urged to Explore Class Action Options
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site